PMCC PMCC

Search tips
Search criteria

Advanced
Results 1-25 (83)
 

Clipboard (0)
None

Select a Filter Below

Year of Publication
more »
1.  Very important pharmacogene summary for VDR 
Pharmacogenetics and genomics  2012;22(10):758-763.
doi:10.1097/FPC.0b013e328354455c
PMCID: PMC3678550  PMID: 22588316
drug response; genetic variants; pharmacogenomics; vitamin D receptor
2.  PharmGKB summary: mycophenolic acid pathway 
Pharmacogenetics and genomics  2014;24(1):73-79.
doi:10.1097/FPC.0000000000000010
PMCID: PMC4091813  PMID: 24220207
immunosuppressive agents; inosine monophosphate dehydrogenase; mycophenolate mofetil; mycophenolic acid; pharmacogenetics; pharmacogenomics
3.  PharmGKB summary: venlafaxine pathway 
Pharmacogenetics and genomics  2014;24(1):62-72.
doi:10.1097/FPC.0000000000000003
PMCID: PMC4098656  PMID: 24128936
CYP2C19; CYP2D6; pharmacogenetics; serotonin–norepinephrine reuptake inhibitor; venlafaxine
4.  PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8 
Pharmacogenetics and genomics  2013;23(12):721-728.
doi:10.1097/FPC.0b013e3283653b27
PMCID: PMC4038626  PMID: 23962911
CYP2C8; CYP2C8*3; metabolism; pharmacogenetics; pharmacogenomics; pharmGKB
5.  PharmGKB summary: tamoxifen pathway, pharmacokinetics 
Pharmacogenetics and genomics  2013;23(11):643-647.
doi:10.1097/FPC.0b013e3283656bc1
PMCID: PMC4084801  PMID: 23962908
breast cancer; pathway; pharmacogenomics; tamoxifen
6.  PharmGKB summary: Gemcitabine Pathway 
Pharmacogenetics and genomics  2014;24(11):564-574.
doi:10.1097/FPC.0000000000000086
PMCID: PMC4189987  PMID: 25162786
Gemcitabine; deoxycytidine analogs; pancreatic cancer; non-small cell lung cancer; breast cancer; pharmacogenomics
7.  Etoposide pathway 
Pharmacogenetics and genomics  2009;19(7):552-553.
doi:10.1097/FPC.0b013e32832e0e7f
PMCID: PMC4164627  PMID: 19512958
etoposide; pathway; pharmacogenetics; pharmacogenomics; pharmGKB
8.  Platinum pathway 
Pharmacogenetics and genomics  2009;19(7):563-564.
doi:10.1097/FPC.0b013e32832e0ed7
PMCID: PMC4153753  PMID: 19525887
anticancer; drug response; pathway; pharmacogenomics; platinum
9.  PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics 
Pharmacogenetics and genomics  2014;24(9):464-476.
doi:10.1097/FPC.0000000000000058
PMCID: PMC4122637  PMID: 24915143
Adverse drug reactions; allopurinol; rasburicase; uric acid; uricosurics; pharmacodynamics; pharmacogenetics
10.  PharmGKB summary: diuretics pathway, pharmacodynamics 
Pharmacogenetics and genomics  2013;23(8):449-453.
doi:10.1097/FPC.0b013e3283636822
PMCID: PMC4084786  PMID: 23788015
diuretics; hypertension; pathway; pharmacogenetic; pharmacogenomic
11.  PharmGKB Summary: Very Important Pharmacogene information for N-acetyltransferase 2 
Pharmacogenetics and genomics  2014;24(8):409-425.
doi:10.1097/FPC.0000000000000062
PMCID: PMC4109976  PMID: 24892773
Acetylation; acetylator; NAT1; NAT2; metabolism; pharmacokinetics; genotype; pharmacogenetics; drug toxicity
12.  PharmGKB summary: cyclosporine and tacrolimus pathways 
Pharmacogenetics and genomics  2013;23(10):563-585.
doi:10.1097/FPC.0b013e328364db84
PMCID: PMC4119065  PMID: 23922006
ABCB1; calcineurin; cyclosporine; CYP3A4; CYP3A5; pharmacodynamics; pharmacogenetics; pharmacokinetics; tacrolimus; transplantation
13.  PharmGKB summary: methylene blue pathway 
Pharmacogenetics and genomics  2013;23(9):498-508.
doi:10.1097/FPC.0b013e32836498f4
PMCID: PMC4091817  PMID: 23913015
glucose-6-phosphate dehydrogenase; hemolytic anemia; methemoglobinemia; methylene blue; reduced nicotinamide adenine dinucleotide phosphate; oxidative stress; pentose phosphate pathway; pharmacodynamics; pharmacogenetics; red blood cells
14.  PharmGKB summary: very important pharmacogene information for UGT1A1 
Pharmacogenetics and genomics  2014;24(3):177-183.
doi:10.1097/FPC.0000000000000024
PMCID: PMC4091838  PMID: 24492252
atazanavir; Crigler–Najjar syndrome; Gilbert’s syndrome; indinavir; irinotecan; pharmacogenetics; UGT1A1
15.  PharmGKB summary: abacavir pathway 
Pharmacogenetics and genomics  2014;24(5):276-282.
doi:10.1097/FPC.0000000000000040
PMCID: PMC4074515  PMID: 24625462
abacavir; HIV; HLA-B; HLA-B*57:01; HSP70-HOM; hypersensitivity; pharmacodynamics; pharmacogenetics; pharmacokinetics; PharmGKB
16.  Valproic acid pathway: pharmacokinetics and pharmacodynamics 
Pharmacogenetics and genomics  2013;23(4):236-241.
doi:10.1097/FPC.0b013e32835ea0b2
PMCID: PMC3696515  PMID: 23407051
pathway; pharmacodynamics; pharmacogenomics; pharmacokinetics; valproic acid
17.  PharmGKB Summary: Very Important Pharmacogene Information for Epidermal Growth Factor Receptor (EGFR) 
Pharmacogenetics and genomics  2013;23(11):636-642.
doi:10.1097/FPC.0b013e3283655091
PMCID: PMC3966564  PMID: 23962910
Epidermal growth factor receptor (EGFR); tyrosine kinase inhibitor; erlotinib; gefitinib; pharmacogenomics
18.  PharmGKB summary: zidovudine pathway 
Pharmacogenetics and genomics  2012;22(12):891-894.
doi:10.1097/FPC.0b013e32835879a8
PMCID: PMC3696524  PMID: 22960662
ABCC4; ABCB1; HIV infection; UGT2B7; zidovudine
19.  Metformin pathways: pharmacokinetics and pharmacodynamics 
Pharmacogenetics and genomics  2012;22(11):820-827.
doi:10.1097/FPC.0b013e3283559b22
PMCID: PMC3651676  PMID: 22722338
AMP-activated protein kinase; diabetes mellitus; metformin; multidrug and toxin extrusion 1; OCT1; OCT2; pathway; pharmacodynamics; pharmacogenomic; pharmacokinetics; type 2 diabetes
20.  PharmGKB Summary - Very Important Pharmacogene Information for Cytochrome P-450, Family 2, Subfamily A, polypeptide 6 (CYP2A6) 
Pharmacogenetics and genomics  2012;22(9):695-708.
doi:10.1097/FPC.0b013e3283540217
PMCID: PMC3413746  PMID: 22547082
CYP2A6; inter-individual variation; pharmacokinetics; genetic polymorphisms; drug metabolism; drug efficacy
21.  PharmGKB summary: very important pharmacogene information for CYP3A5 
Pharmacogenetics and genomics  2012;22(7):555-558.
doi:10.1097/FPC.0b013e328351d47f
PMCID: PMC3738061  PMID: 22407409
CYP3A5; CYP3A5*2; CYP3A5*3; CYP3A5*6; CYP3A5*7; pharmacogenomics; rs10264272; rs28365083; rs76293380; rs776746
22.  PharmGKB summary: caffeine pathway 
Pharmacogenetics and Genomics  2012;22(5):389-395.
doi:10.1097/FPC.0b013e3283505d5e
PMCID: PMC3381939  PMID: 22293536
ADORA2A; caffeine; CYP1A2; pathway; pharmacogenomics
23.  Celecoxib pathways: pharmacokinetics and pharmacodynamics 
Pharmacogenetics and Genomics  2012;22(4):310-318.
doi:10.1097/FPC.0b013e32834f94cb
PMCID: PMC3303994  PMID: 22336956
cardiovascular toxicity; colon cancer; COX-2; coxibs; celecoxib; CYP2C9; drug response; inflammation; nonsteroidal anti-inflammatory drugs; pathway; pharmacogenomics; selective COX-2 inhibitors
24.  PharmGKB summary: very important pharmacogene information for G6PD 
Pharmacogenetics and Genomics  2012;22(3):219-228.
doi:10.1097/FPC.0b013e32834eb313
PMCID: PMC3382019  PMID: 22237549
drug-induced oxidative stress; glucose-6-phosphate dehydrogenase deficiency; hemolytic anemia; pharmacodynamics; pharmacokinetics; polymorphic variants
25.  PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19 
Pharmacogenetics and Genomics  2012;22(2):159-165.
This PharmGKB summary briefly discusses the CYP2C19 gene and current understanding of its function, regulation, and pharmacogenomic relevance.
doi:10.1097/FPC.0b013e32834d4962
PMCID: PMC3349992  PMID: 22027650
antidepressants; clopidogrel; CYP2C19*17; CYP2C19*2; CYP2C19; proton pump inhibitors; rs4244285

Results 1-25 (83)